Loading...
Pharmaceutical supply chain resilience. An exploratory analysis of vulnerabilities and resilience strategies in the face of dynamic disruptions in the UK pharmaceutical supply chain
Yaroson, Emilia V.
Yaroson, Emilia V.
Publication Date
2019
End of Embargo
Supervisor
Rights
The University of Bradford theses are licenced under a Creative Commons Licence.
Peer-Reviewed
Open Access status
Accepted for publication
Institution
University of Bradford
Department
Faculty of Management, Law and Social Sciences
Awarded
2019
Embargo end date
Collections
Additional title
Abstract
Pharmaceutical supply chains are susceptible to disruptions which impact on the operational and financial performance of firms as well as patient safety. This study aimed to explore why the Pharmaceutical Supply Chain (PSC) in the UK is susceptible to the impact of dynamic disruptions and examine how resilience strategies have were employed to reduce the effects of these disruptions. The Complex Adaptive System (CAS) theory was used as a framework in an exploratory research design using mixed-methods. The qualitative data were gathered through 23 semi-structured interviews with key supply chain actors across the PSC in the UK to explore their experiences. The findings from these semi-structured interviews were used to develop a survey which was distributed to a broader spectrum of supply chain actors where the final sample from the survey was (n=106). The data were triangulated to discuss the research findings. The initial results revealed power, conflict and complexities as drivers of vulnerabilities in the PSC. Antecedents for building resilience strategies included visibility, flexibility and joint decision making as recovery strategies and resource sharing as the resistance strategy. CAS provided a systemic approach to understanding PSC resilience rather than in parts. In doing so, it took into consideration the various elements that make up the entire system. Thus, vulnerabilities and resilience strategies were outcomes of the interactions between supply chain actors. The findings demonstrated that CAS, as a theory, provided a framework that was beneficial in exploring and gaining insights into PSC resilience. Also, by combining the two datasets (interviews and survey), an original output was proposed -the Pharmaceutical Supply Chain Resilience Framework (PSCRF)- which was used to recommend resilience strategies suitable for mitigating disruptions in the PSC.
Version
Citation
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Thesis
Qualification name
PhD